Archives

Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression

B By reducing dissociation and sedation risk, ALA-3000 may eliminate the ≥2-hour post-dose monitoring requirement, reducing clinic operating costs, improving patient throughput, and supporting a more cost-effective and reimbursement-aligned treatment…

Read MoreAlar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression

THORNE DEBUTS WOMEN’S HEALTH CAMPAIGN WITH MISTY COPELAND AND LANA CONDOR, INTRODUCING NEW CLINICALLY FORMULATED PRODUCTS

B Omni-channel campaign connects women’s lived experiences to biological clarity – grounded in science-backed support NEW YORK, April 6, 2026 /PRNewswire/ — Thorne, the leader in science-backed health and wellness solutions,…

Read MoreTHORNE DEBUTS WOMEN’S HEALTH CAMPAIGN WITH MISTY COPELAND AND LANA CONDOR, INTRODUCING NEW CLINICALLY FORMULATED PRODUCTS

Palindrome Technologies Achieves Milestone ISO/IEC 42001 Accreditation, Setting the Global Standard for AI Trustworthiness and Governance

B PRINCETON, N.J., April 6, 2026 /PRNewswire/ — As the adoption of Artificial Intelligence (AI) accelerates across the global economy, the demand for rigorous oversight and ethical deployment has never…

Read MorePalindrome Technologies Achieves Milestone ISO/IEC 42001 Accreditation, Setting the Global Standard for AI Trustworthiness and Governance